enderView.ai
Sign InStart free
ClosedSuppliesEuropeanOpenGreen

MenACWY (Vaccinations against Meningococcal infections)

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Open · 1 lots · 375648
Type
Supplies
33651600
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

RIVM has concluded an open tender for MenACWY vaccines (RIVM-375648) for the National Immunisation Programme and Caribbean Netherlands. The procurement is closed; the deadline was 6-June-2025 at 12:00 UTC. The specific CPV code and the total value are missing from the available data.

Supplies · Open · European procedure

Sustainability countsEuropean
Contracting authority
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Contract type
Supplies
Open
Estimated value
Estimate not published
Submission deadline
Ongoing
12:00
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
33651600
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderGreen / SPP

01What is being requested

RIVM has concluded an open tender for MenACWY vaccines (RIVM-375648) for the National Immunisation Programme and Caribbean Netherlands. The procurement is closed; the deadline was 6-June-2025 at 12:00 UTC. The specific CPV code and the total value are missing from the available data.

The assignment concerns the tendering and concluding of contracts for MenACWY vaccines for use in the National Immunisation Programme (including Caribbean Netherlands). The vaccines are administered at the ages of 14 months and 14 years. The requirement for MenACWY vaccine is 200,000 doses in the first year and approximately 320,000 doses in the optional years: • Lot 1 - For children aged 14 months: 80,000 doses in the first contract year and 160,000 ± 15% doses in the second through fourth contract years • Lot 2 – For children around the age of 14 years: 120,000 doses in the first contract ye

33651600Supplies
1MenACWY (Vaccinations against Meningococcal infections)€1

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1Medtronic Trading NL B.V.SME8630×
2Welzorg Nederland B.V.SME8421×
3Boston Scientific Nederland B.V.SME8220×
4Medipoint WMO B.V.SME7715×
5Mediost B.V.SME7714×
6GlaxoSmithKline B.V.SME766×

05Legal themes that may be relevant here

06Frequently asked questions

What is the intended application of the MenACWY vaccines?
The vaccines are intended for use in the National Immunisation Programme, including Caribbean Netherlands, where vaccinations are administered at the ages of 14 months and 14 years.
What is the expected requirement for doses in the first year?
The total requirement for MenACWY vaccine is 200,000 doses in the first year.
What is the distribution of the doses across the different target groups?
For children aged 14 months (lot 1), the requirement is 80,000 doses in the first contract year and 160,000 ± 15% in the second through fourth contract years. For children aged 14 years (lot 2), the requirement is 120,000 doses in the first year and 160,000 ± 15% in the second through fourth contract years.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528